Combination therapy such as radiotherapy
combined with chemotherapy
has attracted excessive interest in the new cancer research area.
Therefore, developing nanobiomaterials for combination of radiotherapy
and chemotherapy is required for more powerful and successful cures.
Because of the amazing X-ray sensitization proficiency of Bi based
nanoparticles, in this work, we synthesized and used Bi2S3 as an enhancer of X-ray radiation therapy, and furthermore,
Bi2S3 served as carrier of curcumin (CUR), a
chemotherapy drug, for the goal of combination therapy. Additionally,
we selected and conjugated folic acid (FA) as a targeting molecule
for the direction of the designed system to the tumor site. After
characterization of drug loaded FA conjugated Bi2S3@BSA nanoparticles (Bi2S3@BSA-FA-CUR)
and in vitro and in vivo safety
assessment, we applied it for enhanced chemotherapy and X-ray radiation
therapy in cancer cells and a tumor bearing mice model. Moreover,
the CT contrast ability of synthesized nanoparticles was examined.
Here, we (1) for the first time developed the novel and targeted CUR
loaded Bi2S3@BSA (Bi2S3@BSA-FA-CUR) to promote chemoradiation therapy in 4T1 cells and breast
tumor in mice; (2) found the synthesized nanoparticles to have good
stability; (3) injected a single dose of the designed radiosensitizer
for cancer therapy; and (4) used a conventional X-ray dose, 2Gy, for
X-ray radiation therapy. The result of in vivo X-ray
radiotherapy shows that the mice tumors vanished near 3 weeks after
radiation. Interestingly, these results show that Bi2S3@BSA-FA-CUR with the aid of X-ray can clearly promote the
efficacy of chemoradiation therapy.